4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-045432
Chief Executive Officer bought 88,000 shares at $1.26 ($110,880)
From the SEC's structured data for this filing
Trades in this filing
Thye Dirk · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-10 | Purchase : show line 1 in the form | +88,000 | $1.26 | $110,880 | 448,911 | D |
| Open-market purchases · 88,000 sh · avg $1.26 · $110,880 | ||||||
Loading xslF345X05/doc4.xml…